esg división médica

Hypertension affects more than 70 million adults in the United States, and even more individuals remain undiagnosed. Hypertension increases the risk of developing other serious health conditions, such as heart attacks, kidney damage, and stroke. Even though there are multiple devices on the market that enable people to track their blood pressure at home, consumer adoption of these self-monitoring devices has remained somewhat limited due to persistent deficits in design, portability, accuracy, and/or usability. MOCACARE, a Silicon Valley company focused on developing consumer cardiovascular monitoring devices–with their flagship product, MOCAheart–just unveiled their cutting edge, wireless, and automatic wrist blood pressure monitor, MOCACuff. We at Medgadget were one of the first to test this new device to see what sets it apart from other currently available home blood pressure monitors. MOCACuff has been granted FDA clearance in the United States and is CE-Certified in the Europ

--  בס"ד CONTACTO

Ascensia Diabetes Care, a company based in Basel, Switzerland, won FDA clearance to bring to the U.S. market its CONTOUR NEXT ONE blood glucometer. The device has Bluetooth wireless connectivity that allows diabetics to upload their readings to a paired app on their iOS or Android smartphones. The CONTOUR DIABETES app provides historical charts of blood sugar levels and lets patients understand how their diet and physical activity impacts those. This works best if the patient religiously enters the details of his/or her food intake and all the activities that take place throughout the day. All the readings and entered information can be uploaded to the “cloud” and reviewed on a computer. Reports can be emailed to one’s physician or family members to make sure everyone is on the same page and helping to keep the symptoms of diabetes in check. The device works just fine on its own without the app, displaying readings on a built-in screen. An indicator on the left side of the

Approximately 890 deaths from coronary heart disease occur outside of the hospital or emergency room every day. Most of these deaths are due to the sudden loss of heart function or sudden cardiac death.1 In 2001 and 2002, there were 6628 workplace fatalities reported to OSHA; 1216 from heart attack, 354 from electric shock, and 267 from asphyxia. A number of these victims, up to 60 percent, might have been saved if automated external defibrillators (AEDs) were immediately available. Chances of survival from sudden cardiac death diminish by 7 - 10 percent for each minute without immediate CPR or defibrillation. After 10 minutes, resuscitation rarely succeeds. An AED is an electronic device designed to deliver an electric shock to a victim of sudden cardiac arrest. Ventricular fibrillation may be restored to normal rhythm up to 60 percent of the time if treated promptly with an AED, a procedure called defibrillation. AEDs in the Workplace Automated external defibrillators (

-- בס"ד CONTACTO

One Drop, a company based in New York City, has announced that it received FDA clearance and CE Mark approval to introduce its One Drop | Chrome blood glucose meter. The device is part of the firm’s One Drop | Premium subscription service that includes the meter, unlimited testing strips, and live support from diabetes professionals via a smartphone app. The service costs $39.95 without insurance and includes the Chrome glucometer that uses Bluetooth to upload readings to the One Drop app, testing strips shipped on demand, and assistance of experts. The experts can lead a patient through programs to help control blood sugar levels, define goals, and explain various issues. The app keeps a record of all the readings and interactions with the professional experts, which can be shared with one’s doctor and family members.

BENEFITS AT A GLANCE: Relaxes muscle tissue Enhances general well-being Increases fertility Strenghtens the immune system Facilitates the healing process Increased appetite